Inhibition of Wnt/β-catenin signaling by monensin in cervical cancer.

Autor: Bingbing Fu¹, Lixia Fang¹, Ranran Wang¹ wangranran@hbuas.edu.cn, Xueling Zhang¹ zhangxueling@hbuas.edu.cn

Publikováno v: Korean Journal of Physiology & Pharmacology. Jan2024, Vol. 28 Issue 1, p21-30. 10p.

Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.

Autor: Fang T; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; Department of Comparative Medicine, Affiliated Hospital of Medicine School, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, China., Hu S; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Song X; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Wang J; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Zuo R; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Yun S; Department of Comparative Medicine, Affiliated Hospital of Medicine School, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, China., Jiang S; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. jiangshanxiang@163.com.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. jiangshanxiang@163.com., Guo D; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. gdawei0123@njau.edu.cn.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. gdawei0123@njau.edu.cn.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 435-451. Date of Electronic Publication: 2024 Jul 03.

HMGA1 stimulates cancer stem-like features and sensitivity to monensin in gastric cancer.

Autor: Pádua D; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-465, Porto, Portugal; ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313, Porto, Portugal., Figueira P; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-465, Porto, Portugal., Pombinho A; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IBMC-Institute of Molecular and Cell Biology, University of Porto, 4200-135, Porto, Portugal., Monteiro I; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-465, Porto, Portugal., Pereira CF; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517, Coimbra, Portugal; Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, BMC A12, 221 84, Lund, Sweden; Wallenberg Center for Molecular Medicine, Lund University, 221 84, Lund, Sweden., Almeida R; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-465, Porto, Portugal., Mesquita P; i3S-Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-465, Porto, Portugal. Electronic address: pmesquita@ipatimup.pt.

Publikováno v: Experimental cell research [Exp Cell Res] 2024 Oct 01; Vol. 442 (2), pp. 114257. Date of Electronic Publication: 2024 Sep 16.

Ultrastructural changes in cardiac and skeletal myoblasts following in vitro exposure to monensin, salinomycin, and lasalocid.

Autor: Henn D; Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa., Lensink AV; Electron Microscope Unit, Department of Anatomy and Physiology, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa., Botha CJ; Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa.

Publikováno v: PloS one [PLoS One] 2024 Sep 25; Vol. 19 (9), pp. e0311046. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).

Comparison of solubility profiles for pioneer and generic monensin premixes in biorelevant simulated intestinal fluid based on shake flask extractions.

Autor: Krabel BJ; Elanco Animal Health, Greenfield, Indiana, USA., Foust LB; Elanco Animal Health, Greenfield, Indiana, USA., Fuller GB; Elanco Animal Health, Greenfield, Indiana, USA., Hunter RP; One Medicine Consulting, Olathe, Kansas, USA.

Publikováno v: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2024 Jul; Vol. 47 (4), pp. 288-293. Date of Electronic Publication: 2024 Feb 26.